Latest News

The Justice Department was forced to use the “legal process” to obtain information related to Federal Reserve Chairman Jerome Powell’s congressional testimony about renovations

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ:CRSP), has come under renewed pressure in recent weeks, amid insider sales, slow revenue growth, and weak adoption

TLDR Table of Contents Bitcoin ETFs recorded a $6.84 million daily net inflow, with cumulative inflows reaching $56.50 billion as of January 26. IBIT

The popularity slump follows controversies surrounding federal enforcement operations, including two fatal shootings in Minnesota.

Donald Trump had an unfortunately timed lapse in memory while discussing concerns over dementia. The 79-year-old president was being interviewed by New York Magazine

Europe’s nationalist leaders once saw President Trump as an ideological ally. Now, as he threatens European sovereignty, they are seeking distance — at least

Goldman Sachs flagged the possibility that the stock market could see a “catch down” valuations collapse in the tech sector.

We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year …

Warren Buffett Once Called These Stocks’ Dividend Growth “as Certain as Birthdays.” Here’s How They’re Doing. Buffett pointed to these two stocks as examples

Figma ( FIG +0.83%) was a hot stock when it went public in the summer of 2025. But after initially rocketing higher, the stock